You can buy or sell Inogen and other stocks, options, ETFs, and crypto commission-free!
Inogen, Inc . engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its products consists of Inogen One G4 system, Inogen One G3 system, Inogen One G2 system, and Inogen at Home. Read More The company was founded by Alison Perry, Alison Bauerlein, Brenton Taylor and Byron Myers on November 27, 2001 and is headquartered in Goleta, CA.
52 Week High
52 Week Low
Advertising and Marketing
Up or Down: Inogen Inc (NASDAQ: INGN)
Inogen Inc trades as part of the medical devices industry and trades as part of the healthcare sector. The company CEO is Scott Wilkinson. Inogen Inc is a medical technology company that develops, manufactures and markets portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Previous Intraday Trading Performance: The INGN stock showed a previous change of 1.51% with an open at 93.08 and a close of 94.68. It reached an...
PR NewswireMar 21
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Inogen, Inc.; Investors with Losses in Excess of $100K are Encouraged to Contact the Firm - INGN
NEW YORK, March 21, 2019 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Inogen, Inc.
Associated PressMar 19
Glancy Prongay & Murray LLP Announces Investigation on Behalf of Inogen, Inc. Investors
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation. This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation. LOS ANGELES--(BUSINESS WIRE)--Mar 19, 2019--Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of Inogen, Inc. investors (“Inogen” or the “Company”) (NASDAQ: INGN ) concerning the Company and its officers’ ...
Expected Apr 29, After Hours